Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates (CROSBI ID 274317)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Bosak, Anita ; Bavec, Aljoša ; Konte, Tilen ; Šinko, Goran ; Kovarik, Zrinka ; Goličnik, Marko Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates // Molecules, 25 (2020), 1; 1-15. doi: 10.3390/molecules25010211

Podaci o odgovornosti

Bosak, Anita ; Bavec, Aljoša ; Konte, Tilen ; Šinko, Goran ; Kovarik, Zrinka ; Goličnik, Marko

engleski

Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates

Mammalian paraoxonase-1 hydrolyses a very broad spectrum of esters such as certain drugs and xenobiotics. The aim of this study was to determine whether carbamates influence the activity of recombinant PON1 (rePON1). Carbamates were selected having a variety of applications: bambuterol and physostigmine are drugs, carbofuran is used as a pesticide, while Ro 02- 0683 is diagnostic reagent. All the selected carbamates reduced the arylesterase activity of rePON1 towards the substrate S-phenyl thioacetate (PTA). Inhibition dissociation constants (Ki), evaluated by both discontinuous and continuous inhibition measurements (progress curves), were similar and in the mM range. The rePON1 displayed almost the same values of Ki constants for Ro 02-0683 and physostigmine while, for carbofuran and bambuterol, the values were approximately ten times lower and two times higher, respectively. The anity of rePON1 towards the tested carbamates was about 3–40 times lower than that of PTA. Molecular modelling of rePON1-carbamate complexes suggested non-covalent interactions with residues of the rePON1 active site that could lead to competitive inhibition of its arylesterase activity. In conclusion, carbamates can reduce the level of PON1 activity, which should be kept in mind, especially in medical conditions characterized by reduced PON1 levels.

paraoxonase-1 ; arylesterase activity ; phenyl acetate ; S-phenyl thioacetate ; p-nitrophenyl acetate ; carbamates ; reversible inhibition

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

25 (1)

2020.

1-15

objavljeno

1420-3049

10.3390/molecules25010211

Povezanost rada

Farmacija, Kemija, Temeljne medicinske znanosti

Poveznice
Indeksiranost